- Home
- SCOR vs CRIS Comparison
SCOR vs CRIS Comparison
Compare SCOR & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- CRIS
- Stock Information
- Founded
- SCOR 1999
- CRIS 2000
- Country
- SCOR United States
- CRIS United States
- Employees
- SCOR N/A
- CRIS N/A
- Industry
- SCOR Business Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SCOR Consumer Discretionary
- CRIS Health Care
- Exchange
- SCOR Nasdaq
- CRIS Nasdaq
- Market Cap
- SCOR 29.0M
- CRIS 32.8M
- IPO Year
- SCOR 2007
- CRIS 2000
- Fundamental
- Price
- SCOR $6.67
- CRIS $1.48
- Analyst Decision
- SCOR Buy
- CRIS Strong Buy
- Analyst Count
- SCOR 2
- CRIS 3
- Target Price
- SCOR $10.75
- CRIS $21.00
- AVG Volume (30 Days)
- SCOR 18.4K
- CRIS 51.0K
- Earning Date
- SCOR 03-04-2025
- CRIS 03-31-2025
- Dividend Yield
- SCOR N/A
- CRIS N/A
- EPS Growth
- SCOR N/A
- CRIS N/A
- EPS
- SCOR N/A
- CRIS N/A
- Revenue
- SCOR $356,047,000.00
- CRIS $10,908,000.00
- Revenue This Year
- SCOR $4.01
- CRIS N/A
- Revenue Next Year
- SCOR $4.03
- CRIS $27.88
- P/E Ratio
- SCOR N/A
- CRIS N/A
- Revenue Growth
- SCOR N/A
- CRIS 8.83
- 52 Week Low
- SCOR $4.89
- CRIS $1.42
- 52 Week High
- SCOR $16.41
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- SCOR 50.70
- CRIS 18.52
- Support Level
- SCOR $6.42
- CRIS $2.57
- Resistance Level
- SCOR $7.02
- CRIS $2.62
- Average True Range (ATR)
- SCOR 0.47
- CRIS 0.26
- MACD
- SCOR 0.05
- CRIS -0.07
- Stochastic Oscillator
- SCOR 43.40
- CRIS 10.88
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.